Navigation Links
Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Date:10/6/2009

stated strategy of conducting a well-controlled, Phase III confirmatory clinical trial in addition to its planned U.S. Phase II/III trial in order to establish the efficacy and safety of its product for marketing authorization purposes. Helix intends to continue to make preparations to conduct a European Phase III trial for this purpose. The timing of filing the regulatory submissions for this trial has not yet been established, however, it is not expected to precede the filing of its planned U.S. Phase II/III IND.

Topical Interferon Alpha-2b - Anogenital Warts Indication

Enrollment in the ongoing Phase II clinical trial of Topical Interferon Alpha-2b in patients with anogenital warts ("AGW") in Sweden and Germany is progressing on track. The Company expects the last patient to be enrolled on or around the end of the first quarter of fiscal 2010. The study has now enrolled over 85% of the required 120 patients. Future considerations for the AGW program were not part of the latest pre-IND meetings, as Helix is awaiting the results from the ongoing Phase II AGW trial prior to initiating further development plans for this indication.

L-DOS47

At the pre-IND meeting with the FDA for L-DOS47, the FDA generally agreed with Helix's proposed remaining non-clinical pharmacology and toxicology studies as well as its remaining GMP manufacturing program initiatives prior to IND filing. The FDA provided Helix with recommendations for improvements in some areas including the development of additional quality control analytical testing methods to characterize batches of L-DOS47 clinical supplies and their intermediates.

As previously stated, Helix intends to initiate its clinical testing program with L-DOS47 with studies in both North America and in Europe. In Europe, Helix has been developing relationships with key opinion leader clinicians and contract research organizations in Poland with a plan to co
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
4. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
5. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
11. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015   BioLife Solutions , ... marketer of proprietary clinical grade cell and tissue hypothermic ... related cloud hosted biologistics cold chain management app ... announced that Seattle Business Magazine has included BioLife ... work for in Washington state for ...
(Date:7/2/2015)... Wilson Therapeutics AB , a privately-held biopharmaceutical company, today ... of directors. The appointment was approved by the shareholders ... "We are delighted to welcome Hans to Wilson,s ... of Wilson Therapeutics. "Hans brings significant global biopharmaceutical industry ... contributions to the Company." Hans Schikan is ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Inaugural Healthcare Conference taking place in New ... Le Parker Meridien Hotel. James ... of the Company,s business during his live presentation and ...
Breaking Medicine Technology:BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... DecisionView Inc., a leading provider of software ... sciences companies, today announced the release of StudyOptimizer ... solution for patient enrollment planning, tracking and forecasting. ... site performance and cost projections, StudyOptimizer 4.3 significantly ...
... Mich., July 19, 2011 Terumo Heart, Inc., a ... a patient implanted with the DuraHeart™ Left Ventricular Assist ... the mechanical circulatory support device.  Helga Gieseke, living in ... German Heart Institute Berlin) and is now one of ...
Cached Medicine Technology:DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 2DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 3German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device 2German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device 3
(Date:7/2/2015)... ... 02, 2015 , ... Five individuals from Loma Linda University ... specialized disaster training. The team – composed of four clinicians and one administrative ... who attended the training, which is dedicated to preparing first responders for a ...
(Date:7/2/2015)... ... July 02, 2015 , ... Hand sanitizers have become extremely popular ... season, according to fresh water advocate and radio host Sharon Kleyne, hand sanitizers can ... that for maximum effectiveness, hand sanitizers must be applied correctly and users must be ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... healthcare providers, has been retained to lead a national chief operating officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
(Date:7/2/2015)... ... 2015 , ... Throughout the month of April, Casey’s General Stores invited customers ... Tuesday, July 7, Casey’s General Stores Chairman and CEO, Bob Myers, will present a ... a national nonprofit dedicated to restoring a sense of self, restoring the family unit, ...
(Date:7/2/2015)... ... , ... AvePoint Public Sector, Inc., a wholly owned subsidiary of ... announced it was named the recipient of the 2015 GTRA ConVurge Tech Award for ... the Government Technology Research Alliance (GTRA), was presented June 29 during the ConVurge Honorary ...
Breaking Medicine News(10 mins):Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4
... -- Among HIV-negative sexual partners, male circumcision helps prevent ... according to a new study. However, circumcision offers ... sex, the researchers pointed out. Human papillomavirus (HPV) ... risk for cervical cancer. Previous research has shown that ...
... Mass.Consumers may place a high value on information to predict ... of pocket to get it. In a national survey conducted ... indicated that they would take a hypothetical predictive test to ... or prostate cancer, or arthritis. On average, respondents were willing ...
... FRIDAY, Jan. 7 (HealthDay News) -- A new study finds ... bacteria in the nose are more likely to have other ... potentially fatal infections. Researchers at Rhode Island Hospital wanted ... the body and the relationship between the quantities of MRSA ...
... A study carried out by the University of Granada (UGR) ... waste management in the different autonomous communities to improve recycling ... just a framework law that the Spanish Ministry of the ... reform. , "We carried out a comparison of the ...
... Many prescriptions for the top-selling class of drugs, known ... drugs will actually help, a study by researchers at ... Chicago has found. Yet, drugs in this class may ... heart disease, and cost Americans billions of dollars. ...
... HealthDay Reporter , THURSDAY, Jan. 6 (HealthDay News) ... when treating repeated throat infections in children and resort ... new medical guidelines suggest. A panel of experts ... tonsillectomies -- surgical removal of the tonsils -- found ...
Cached Medicine News:Health News:Circumcision Helps Cut HPV Transmission Rate, Study Finds 2Health News:Most consumers want predictive tests to learn if a disease is in their future 2Health News:Most consumers want predictive tests to learn if a disease is in their future 3Health News:Clinical waste management needs specialized regulation 2Health News:Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher 2Health News:Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher 3Health News:Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher 4Health News: No Surgery for Moderate Tonsillitis, New Guidelines Say 2Health News: No Surgery for Moderate Tonsillitis, New Guidelines Say 3
... the corrosion resistance of stainless steel ... copper, SANYO offers an electro-polished copper-alloy-stainless ... maintenance-free. The sterile environment promotes the ... and the safety of laboratory staff. ...
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
... The F 250 is a portable ... mV and temperature measurements. Temperature compensated pH ... a temperature probe (ATC) or a 3-in-1 ... and three-point calibration with Auto-Find automatic buffer ...
... F 295 is a fully equipped, waterproof system ... and temperature measurements. Temperature compensated pH results can ... (ATC) or a 3-in-1 electrode. Up to five ... system includes an RS-232 interface to connect to ...
Medicine Products: